Class IITerminatedD-1882-2019
Drug recall · October 2, 2019
Oxaliplatin Active Pharmaceutical Ingredient recall
Why: cGMP Deviations: Potential glass contamination
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001, NDC 49821-0075-XX
- Lots / codes
Lot #: B0126-170701; B0126-170802; Exp. Sep 2022; B0126-180401, Exp. May 2023; B0126-180702, B0126-180803, Exp. Oct 2023
- Quantity
- 316703.32
- Company
- Johnson Matthey Inc., West Deptford, NJ
- Distribution
- Nationwide within the United States
- Initiated
- August 29, 2019 · Voluntary: Firm initiated
- Classified
- September 25, 2019
- Reported
- October 2, 2019
- Ended
- January 21, 2022
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.